References

Herrera D, Berglundh T, Schwarz F Prevention and treatment of peri-implant diseases. The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023; 50:4-76 https://doi.org/10.1111/jcpe.13823
Heitz-Mayfield LJA, Salvi GE Peri-implant mucositis. J Clin Periodontol. 2018; 45:S237-S245 https://doi.org/10.1111/jcpe.12953
Berglundh T, Armitage G, Araujo MG Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018; 45:S286-S291 https://doi.org/10.1111/jcpe.12957
Schwarz F, Derks J, Monje A, Wang HL Peri-implantitis. J Clin Periodontol. 2018; 45:S246-S266 https://doi.org/10.1111/jcpe.12954
Bermejo P, Sánchez MC, Llama-Palacios A Topographic characterization of multispecies biofilms growing on dental implant surfaces: an in vitro model. Clin Oral Implants Res. 2019; 30:229-241 https://doi.org/10.1111/clr.13409
Sánchez MC, Llama-Palacios A, Fernández E An in vitro biofilm model associated to dental implants: structural and quantitative analysis of in vitro biofilm formation on different dental implant surfaces. Dent Mater. 2014; 30:1161-1171 https://doi.org/10.1016/j.dental.2014.07.008
Sahrmann P, Gilli F, Wiedemeier DB The microbiome of peri-implantitis: a systematic review and meta-analysis. Microorganisms. 2020; 8 https://doi.org/10.3390/microorganisms8050661
Derks J, Tomasi C Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015; 42:S158-171 https://doi.org/10.1111/jcpe.12334
Lee CT, Huang YW, Zhu L, Weltman R Prevalences of peri-implantitis and peri-implant mucositis: systematic review and meta-analysis. J Dent. 2017; 62:1-12 https://doi.org/10.1016/j.jdent.2017.04.011
Diaz P, Gonzalo E, Villagra LJG What is the prevalence of peri-implantitis? A systematic review and meta-analysis. BMC Oral Health. 2022; 22 https://doi.org/10.1186/s12903-022-02493-8
Rustand K, Aass AM, Sen A, Koldsland OC Oral health-related quality of life following peri-implantitis surgery: a prospective study. Clin Oral Implants Res. 2022; 33:858-867 https://doi.org/10.1111/clr.13967
Renvert S, Persson GR, Pirih FQ, Camargo PM Peri-implant health, peri-implant mucositis, and peri-implantitis: case definitions and diagnostic considerations. J Clin Periodontol. 2018; 45:S278-S285 https://doi.org/10.1111/jcpe.12956
Araujo MG, Lindhe J Peri-implant health. J Clin Periodontol. 2018; 45:S230-S236 https://doi.org/10.1111/jcpe.12952
Peri-implant health, peri-implant mucositis, and peri-implantitis. 2019. http//www.efp.org/fileadmin/uploads/efp/Documents/Campaigns/New_Classification/Guidance_Notes/report-04.pdf (accessed April 2024)
Jepsen S, Berglundh T, Genco R Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015; 42:S152-157 https://doi.org/10.1111/jcpe.12369
Suvan J, Leira Y, Moreno Sancho FM Subgingival instrumentation for treatment of periodontitis. A systematic review. J Clin Periodontol. 2020; 47:155-175 https://doi.org/10.1111/jcpe.13245
Tonetti MS, Sanz M, Avila-Ortiz G Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report. J Clin Periodont. 2023; 50:5-21 https://doi.org/10.1111/jcpe.13808

An update on the prevention and treatment of peri-implant diseases

From Volume 51, Issue 5, May 2024 | Pages 360-368

Authors

Payvand Menhadji

BDS (Hons) BSc (Hons) MFDS RCS (Ed) Pg Cert Dent Ed, BDS (Hons), BSc (Hons), MFDS RCS (Ed), PgCert Dent Ed

Periodontology Specialist Trainee, Periodontology Unit, Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London

Articles by Payvand Menhadji

Email Payvand Menhadji

Emily Ming-Chieh Lu

BDS, MClinDent Perio, PhD, MFDS RCSEng, MPerio RCSEd, FHEA

Clinical Lecturer/Honorary Consultant in Periodontology, Centre for Host–Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, Kings College London

Articles by Emily Ming-Chieh Lu

Abstract

Peri-implant diseases, especially peri-implantitis, present a growing public health concern owing to their rising prevalence and adverse outcomes, and lead to substantial dental care costs and an overall economic impact. This article outlines the case definitions and diagnoses for peri-mucositis and peri-implantitis and summarizes the EFP S3-level clinical practice guidelines.

CPD/Clinical Relevance: Understanding case definitions and diagnoses of peri-implant diseases, including peri-mucositis and peri-implantitis, is essential for dental professionals to provide effective treatment and prevent complications.

Article

Managing peri-implant diseases, which are linked to considerable morbidity, poses significant challenges. The latest clinical practice guidelines1 seek to identify optimal interventions for maintaining peri-implant tissue health, aiming to prolong the complication-free survival of dental implants used in tooth replacement. Peri-implant diseases, driven by peri-implant biofilms, manifest as inflammatory conditions affecting peri-implant tissues, with two distinct conditions: peri-implant mucositis and peri-implantitis. Peri-implant diseases, especially peri-implantitis, present a growing public health concern owing to their rising prevalence and adverse outcomes, such as implant and prosthesis loss, leading to substantial dental care costs and have an overall economic impact.

Peri-implant mucositis, as defined by Heitz-Mayfield and Salvi,2 is an inflammatory condition affecting the peri-implant mucosa without concurrent marginal bone loss. Clinically, it manifests as bleeding upon gentle probing, accompanied by potential signs of inflammation, such as erythema, swelling and/or suppuration. The condition is associated with increased probing depth, attributed to oedema or diminished probing resistance. Disruption of host-microbial homeostasis at the implant–mucosa interface is the underlying cause, making it a reversible condition when assessed through host biomarkers. Contributing factors include biofilm accumulation, smoking, and radiation therapy.3

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available